Drug Markets/Risedronate Sodium

Risedronate Sodium

24 NDCs across 7 manufacturers|21 Generic,3 Brand

Risedronate Sodium is used to treat postmenopausal osteoporosis and extramammary paget disease, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Mar 27, 1998, and the first generic was approved Oct 5, 2007. FDA's Orange Book lists 25 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $27 million on Risedronate Sodium across 284,000 claims for 85,000 beneficiaries.

Risedronate Sodium is available as 24 NDCs from 7 manufacturers (21 generic, 3 brand), with NADAC prices from $1.50 to $353.50 per EAthe most expensive product costs about 236× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

24

21G / 3B

Manufacturers

7

competing in market

Price Spread

$1.50 – $353.50

per EA

7d Activity

4191 flat

avg -6.7% WoW · of 24 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

24 NDCs total, 24 shown

Drug Price 7d Change
ACTONEL 150 MG TABLET
$353.4980
per EA
ACTONEL 35 MG TABLET
$81.8555
per EA
ATELVIA DR 35 MG TABLET
$63.8494
per EA
-0.08%
RISEDRONATE SOD DR 35 MG TAB
$29.8417
per EA
+3.72%
RISEDRONATE SOD DR 35 MG TAB
$25.0977
per EA
RISEDRONATE SODIUM 150 MG TAB
$12.8176
per EA
-6.74%
RISEDRONATE SODIUM 150 MG TAB
$12.8176
per EA
-6.74%
RISEDRONATE SODIUM 150 MG TAB
$12.8176
per EA
-6.74%
RISEDRONATE SODIUM 150 MG TAB
$12.8176
per EA
-6.74%
RISEDRONATE SODIUM 150 MG TAB
$12.8176
per EA
-6.74%
RISEDRONATE SODIUM 150 MG TAB
$12.8176
per EA
-6.74%
RISEDRONATE SODIUM 150 MG TAB
$12.8176
per EA
-6.74%
RISEDRONATE SODIUM 35 MG TAB
$12.6541
per EA
RISEDRONATE SODIUM 35 MG TAB
$12.6541
per EA
RISEDRONATE SODIUM 35 MG TAB
$2.0137
per EA
-12.34%
RISEDRONATE SODIUM 35 MG TAB
$2.0137
per EA
-12.34%
RISEDRONATE SODIUM 35 MG TABLET
$2.0137
per EA
-12.34%
RISEDRONATE SODIUM 35 MG TAB
$2.0137
per EA
-12.34%
RISEDRONATE SODIUM 35 MG TAB
$2.0137
per EA
-12.34%
RISEDRONATE SODIUM 35 MG TAB
$2.0137
per EA
-12.34%
RISEDRONATE SODIUM 35 MG TABLET
$2.0137
per EA
-12.34%
RISEDRONATE SODIUM 35 MG TAB
$2.0137
per EA
-12.34%
RISEDRONATE SODIUM 5 MG TABLET
$1.4976
per EA
+1.88%
RISEDRONATE SODIUM 5 MG TABLET
$1.4976
per EA
+1.88%

Frequently Asked Questions

What is Risedronate Sodium used to treat?

Risedronate Sodium is used to treat postmenopausal osteoporosis and extramammary paget disease, per the National Library of Medicine's MED-RT classification.

When did Risedronate Sodium become available as a generic?

FDA approved the first generic Risedronate Sodium (ANDA) on Oct 5, 2007. The Orange Book currently lists 25 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Risedronate Sodium?

In 2024, Medicare Part D spent $27 million on Risedronate Sodium across 284,000 claims for 85,000 beneficiaries.

How many Risedronate Sodium products are on the market?

The Risedronate Sodium drug market contains 24 NDCs from 7 manufacturers — 21 generic and 3 brand products.

What is the price range for Risedronate Sodium?

NADAC reference prices for Risedronate Sodium range from $1.4976 to $353.4980 per EA — the most expensive product costs about 236× the cheapest.

Is generic Risedronate Sodium cheaper than brand?

The average generic NADAC for Risedronate Sodium is $9.0036 per EA, versus $166.4010 for brand-labeled products — brand versions average about 18× the generic price.

Which manufacturers make Risedronate Sodium?

7 manufacturers list Risedronate Sodium in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (5), Aurobindo Pharma Limited (4), Allergan, Inc. (3), Mylan Pharmaceuticals Inc. (3), Apotex Corp. (3).

How has the price of Risedronate Sodium changed recently?

Over the past 7 days, 4 Risedronate Sodium NDCs rose and 19 fell, with a market-wide average change of -6.7%.